Publication | Closed Access
Oxaliplatin, 5-Fluorouracil, and Leucovorin as Second-Line Treatment for Advanced Pancreatic Cancer
36
Citations
25
References
2009
Year
The median TTP and median OS in this population with poor prognosis suggests some activity, however, only further investigations will be able to establish the clinical value of this combination.
| Year | Citations | |
|---|---|---|
Page 1
Page 1